119 related articles for article (PubMed ID: 37619822)
1. ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer through VEGF upregulation.
Jiang Y; Huang J; Huang Z; Li W; Tan R; Li T; Chen Z; Tang X; Zhao Y; Qiu J; Li C; Chen H; Yang Z
Cell Signal; 2023 Nov; 111():110866. PubMed ID: 37619822
[TBL] [Abstract][Full Text] [Related]
2. The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway.
Llamazares M; Obaya AJ; Moncada-Pazos A; Heljasvaara R; Espada J; López-Otín C; Cal S
J Cell Sci; 2007 Oct; 120(Pt 20):3544-52. PubMed ID: 17895370
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.
Tang X; Liang Y; Sun G; He Q; Hou Z; Jiang X; Gao P; Qu H
Cell Death Dis; 2022 Oct; 13(10):848. PubMed ID: 36195596
[TBL] [Abstract][Full Text] [Related]
4. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
[TBL] [Abstract][Full Text] [Related]
5. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
6. PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer.
Huang W; Han Z; Sun Z; Feng H; Zhao L; Yuan Q; Chen C; Yu S; Hu Y; Yu J; Liu H; Li G; Jiang Y
Cell Death Dis; 2022 Jul; 13(7):658. PubMed ID: 35902562
[TBL] [Abstract][Full Text] [Related]
7. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
8. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
9. ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer.
He RZ; Zheng JH; Yao HF; Xu DP; Yang MW; Liu DJ; Sun YW; Huo YM
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):169-178. PubMed ID: 35508435
[TBL] [Abstract][Full Text] [Related]
10. HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer.
Wang MQ; Chen YR; Xu HW; Zhan JR; Suo DQ; Wang JJ; Ma YZ; Guan XY; Li Y; Zhu SL
Cancer Sci; 2023 Apr; 114(4):1365-1377. PubMed ID: 36519789
[TBL] [Abstract][Full Text] [Related]
11. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
[TBL] [Abstract][Full Text] [Related]
12. Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
Lin C; Lin P; Yao H; Liu S; Lin X; He R; Teng Z; Zuo X; Li Y; Ye J; Zhu G
Cancer Lett; 2024 Apr; 587():216712. PubMed ID: 38364962
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer.
Hou Y; Xu Y; Wu D
Sci Rep; 2021 May; 11(1):10996. PubMed ID: 34040054
[TBL] [Abstract][Full Text] [Related]
14. Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
Gao Q; Huang C; Liu T; Yang F; Chen Z; Sun L; Zhao Y; Wang M; Luo L; Zhou C; Zhu W
J Cell Biochem; 2024 Mar; 125(3):e30521. PubMed ID: 38226525
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis.
Yang S; Zhou X; Jia Z; Zhang M; Yuan M; Zhou Y; Wang J; Xia D
Mol Med; 2023 Jul; 29(1):86. PubMed ID: 37400752
[TBL] [Abstract][Full Text] [Related]
16. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment.
Wang D; Jiao Z; Ji Y; Zhang S
J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth.
Wang X; Chen X; Fang J; Yang C
Int J Clin Exp Pathol; 2013; 6(4):586-97. PubMed ID: 23573305
[TBL] [Abstract][Full Text] [Related]
18. Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer.
Qu X; Liu B; Wang L; Liu L; Zhao W; Liu C; Ding J; Zhao S; Xu B; Yu H; Zhang X; Chai J
Drug Resist Updat; 2023 May; 68():100936. PubMed ID: 36764075
[TBL] [Abstract][Full Text] [Related]
19. LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis.
Lin M; Xu M; Xu Z; Weng Z; Lin B; Lan Y; Liu Q; Lin X; Pan J
Hum Cell; 2021 Jul; 34(4):1163-1173. PubMed ID: 33822325
[TBL] [Abstract][Full Text] [Related]
20. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Zhu YZ; Liu Y; Liao XW; Luo SS
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]